1. Carter SK (1984) Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn’t. J Clin Oncol 2:147–148
2. De Vita VT (1984) Opening comments: only if you believe in magic. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer IV. Grune and Stratton, Orlanda, pp 3–16
3. Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67: 923–931
4. Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66: 439–449
5. Griswold DP Jr (1972) Consideration of the subcutaneously implanted B16 malanoma as a screening model for potential anticancer agents. Cancer Chemother Rep 3: 315–324